James R. Gruber - 03 Jan 2025 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Chief Financial Officer
Signature
/s/ James R. Gruber
Issuer symbol
ETON
Transactions as of
03 Jan 2025
Net transactions value
$0
Form type
4
Filing time
06 Jan 2025, 16:15:21 UTC
Previous filing
15 Feb 2024
Next filing
20 Aug 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETON Employee Stock Option (Right to Buy) Award $0 +38,621 $0.000000 38,621 03 Jan 2025 Common Stock 38,621 $13.00 Direct F1
transaction ETON Restricted Stock Units Award $0 +25,876 $0.000000 25,876 03 Jan 2025 Common Stock 25,876 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029.
F2 Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
F3 The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.